Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.

Yong C, Wang Z, Zhang X, Shi X, Ni Z, Fu H, Ding G, Fu Z, Yin H.

Int J Nanomedicine. 2014 Feb 17;9:985-93. doi: 10.2147/IJN.S55812. eCollection 2014.

2.

A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetes.

He Q, Zhang X, Han B, Xu J, Tang K, Fu Z, Yin H.

Theranostics. 2014 Mar 5;4(5):556-64. doi: 10.7150/thno.7847. eCollection 2014.

3.

The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patients.

Yin H, Gao M, Leoni L, Han H, Zhang X, Fu Z.

PLoS One. 2013;8(2):e57635. doi: 10.1371/journal.pone.0057635. Epub 2013 Feb 25.

4.

Effect of nicotinamide on early graft failure following intraportal islet transplantation.

Jung DY, Park JB, Joo SY, Joh JW, Kwon CH, Kwon GY, Kim SJ.

Exp Mol Med. 2009 Nov 30;41(11):782-92. doi: 10.3858/emm.2009.41.11.084.

5.

Reversal of diabetes by the creation of neo-islet tissues into a subcutaneous site using islet cell sheets.

Saito T, Ohashi K, Utoh R, Shimizu H, Ise K, Suzuki H, Yamato M, Okano T, Gotoh M.

Transplantation. 2011 Dec 15;92(11):1231-6. doi: 10.1097/TP.0b013e3182375835.

PMID:
22124282
6.

A bioengineered drug-Eluting scaffold accelerated cutaneous wound healing In diabetic mice.

Yin H, Ding G, Shi X, Guo W, Ni Z, Fu H, Fu Z.

Colloids Surf B Biointerfaces. 2016 Sep 1;145:226-231. doi: 10.1016/j.colsurfb.2016.04.056. Epub 2016 May 3.

PMID:
27187186
7.

Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.

Dao LT, Park EY, Lim SM, Choi YS, Jung HS, Jun HS.

Transplantation. 2014 Nov 27;98(10):1040-7. doi: 10.1097/TP.0000000000000388.

PMID:
25208321
8.

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.

Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, Bianchi G, Sica A, Peri G, Melzi R, Aldrighetti L, Secchi A, Di Carlo V, Allavena P, Bertuzzi F.

Diabetes. 2002 Jan;51(1):55-65.

9.

Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets.

Liu JMH, Zhang J, Zhang X, Hlavaty KA, Ricci CF, Leonard JN, Shea LD, Gower RM.

Biomaterials. 2016 Feb;80:11-19. doi: 10.1016/j.biomaterials.2015.11.065. Epub 2015 Dec 2.

11.

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G.

Diabetes. 2009 Sep;58(9):2109-18. doi: 10.2337/db08-0895. Epub 2009 Jul 8.

12.

Reversal of hyperglycemia in diabetic mice by a marginal islet mass together with human blood outgrowth endothelial cells is independent of the delivery technique and blood clot-induced processes.

Coppens V, Heremans Y, Leuckx G, Suenens K, Jacobs-Tulleneers-Thevissen D, Verdonck K, Luttun A, Heimberg H, De Leu N.

Islets. 2013 Sep-Dec;5(5):196-200. doi: 10.4161/isl.26778. Epub 2013 Nov 8.

13.
14.

Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.

Sakata N, Sumi S, Gu Y, Qi M, Yamamoto C, Sunamura M, Egawa S, Unno M, Matsuno S, Inoue K.

Pancreas. 2007 May;34(4):458-65.

PMID:
17446846
15.
16.
17.

The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells.

Mao GH, Chen GA, Bai HY, Song TR, Wang YX.

Biomaterials. 2009 Mar;30(9):1706-14. doi: 10.1016/j.biomaterials.2008.12.030. Epub 2009 Jan 8.

PMID:
19135250
18.

Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.

Lee I, Wang L, Wells AD, Ye Q, Han R, Dorf ME, Kuziel WA, Rollins BJ, Chen L, Hancock WW.

J Immunol. 2003 Dec 15;171(12):6929-35.

19.

Effect of retinoic acid in experimental diabetic nephropathy.

Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR.

Immunol Cell Biol. 2004 Dec;82(6):568-76.

20.

Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts.

Nakano M, Yasunami Y, Maki T, Kodama S, Ikehara Y, Nakamura T, Tanaka M, Ikeda S.

Transplantation. 2000 Jan 27;69(2):214-21.

PMID:
10670629

Supplemental Content

Support Center